Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Return on Equity (2021 - 2025)

Biofrontera has reported Return on Equity over the past 5 years, most recently at 2.67% for Q4 2025.

  • Quarterly results put Return on Equity at 2.67% for Q4 2025, up 90.0% from a year ago — trailing twelve months through Dec 2025 was 2.67% (up 90.0% YoY), and the annual figure for FY2025 was 1.41%, up 244.0%.
  • Return on Equity for Q4 2025 was 2.67% at Biofrontera, down from 4.85% in the prior quarter.
  • Over the last five years, Return on Equity for BFRIW hit a ceiling of 74.13% in Q1 2024 and a floor of 22.39% in Q2 2021.
  • Median Return on Equity over the past 5 years was 1.56% (2024), compared with a mean of 2.22%.
  • Biggest five-year swings in Return on Equity: soared 7480bps in 2024 and later tumbled -7880bps in 2025.
  • Biofrontera's Return on Equity stood at 12.48% in 2021, then crashed by -100bps to 0.03% in 2022, then plummeted by -24969bps to 6.9% in 2023, then skyrocketed by 48bps to 3.56% in 2024, then increased by 25bps to 2.67% in 2025.
  • The last three reported values for Return on Equity were 2.67% (Q4 2025), 4.85% (Q3 2025), and 7.96% (Q2 2025) per Business Quant data.